
Funding Opportunities
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21) RFA-CA-16-001 |
Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) RFA-CA-16-003 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) RFA-CA-16-002 |
Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) RFA-CA-16-004 |
Subcontract Opportunity - Thrombosis in Cancer Patients Application Receipt Date: See additional details Proposal Due Date: May 27, 2015 |
Proteogenomic Translational Research for Clinical Proteomic Tumor Analysis Consortium (U01) RFA-CA-15-022 |
NCI Requests Cancer Targets for Monoclonal Antibody Production and Characterization Application Receipt Date: February 5, 2016 |
Proteome Characterization Centers for Clinical Proteomic Tumor Analysis Consortium (U24) RFA-CA-15-021 |
Proteogenomic Data Analysis Centers for Clinical Proteomic Tumor Analysis Consortium (U24) RFA-CA-15-023 |
Request for Proposals (RFP S16-074) for production of Affinity Binders Application Receipt Date: January 22, 2016 http://ncioa.cancer.gov/oa-internet/sbo/rqmt/allsolicit?execution=e1s1 |
Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) - Total Small Business Set-Aside Application Receipt Date: Multiple dates, see announcement https://www.fbo.gov/index?s=opportunity&mode=form&id=6db5cc5322b20262e2c... |
Tissue Purchase Order Acquisitions for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) - Full and Open Competition Application Receipt Date: Multiple dates, see announcement https://www.fbo.gov/index?s=opportunity&mode=form&id=e516eb1a93e67e5100a... |
Innovative Molecular Analysis Technologies for Cancer Research (R21) RFA-CA-15-002 |
Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research (R33) RFA-CA-15-003 |
Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) RFA-CA-15-004 |
Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) RFA-CA-15-005 |
Proteomic Characterization of PS-ON Cell Lines Application Receipt Date: November 21, 2014 |
Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) RFA-CA-14-013 |
Computational Omics - Request for Proposals Application Receipt Date: October 8, 2014 https://proteomics.cancer.gov/news_and_announcements/computational-omics... |
Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21) RFA-CA-14-003 |